Is Neoadjuvant Chemotherapy in Malignant Pleural Mesothelioma Beneficial?
Neoadjuvant chemotherapy was found to negatively impact survival in resectable malignant pleural mesothelioma.
Neoadjuvant chemotherapy was found to negatively impact survival in resectable malignant pleural mesothelioma.
A study affirmed the benefits of a multimodal approach in the assessment of minimal residual disease in multiple myeloma.
How will oncology deal with a lack of medical genetics professionals to help treat cancer with precision genomic medicine?